Paraprobiotics for irritable bowel syndrome: all that glitters is not gold - Authors' reply

Affiliations

¹ Department of Internal Medicine, Israelitic Hospital, University of Hamburg Teaching Hospital, D-22297 Hamburg, Germany.
² Department of Internal Medicine, Hospital Forchheim, Forchheim, Germany.
³ Department of Internal Medicine, Israelitic Hospital, University of Hamburg Teaching Hospital, D-22297 Hamburg, Germany. Electronic address: p.layer@ik-h.de.

Comment

Viola Andresen et al. Lancet Gastroenterol Hepatol. 2020 Sep.

. 2020 Sep;5(9):797-798.

doi: 10.1016/S2468-1253(20)30239-9.

¹ Department of Internal Medicine, Israelitic Hospital, University of Hamburg Teaching Hospital, D-22297 Hamburg, Germany.
² Department of Internal Medicine, Hospital Forchheim, Forchheim, Germany.
³ Department of Internal Medicine, Israelitic Hospital, University of Hamburg Teaching Hospital, D-22297 Hamburg, Germany. Electronic address: p.layer@ik-h.de.

No abstract available

Comment on

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V, Gschossmann J, Layer P. Andresen V, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):658-666. doi: 10.1016/S2468-1253(20)30056-X. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277872 Clinical Trial.
Paraprobiotics for irritable bowel syndrome: all that glitters is not gold.
Enck P, Schemann M, Frieling T. Enck P, et al. Lancet Gastroenterol Hepatol. 2020 Sep;5(9):797. doi: 10.1016/S2468-1253(20)30243-0. Lancet Gastroenterol Hepatol. 2020. PMID: 32818454 No abstract available.